Remission of Refractory Membranous Nephropathy by Low-dose Rituximab: A Case Report

被引：1
|
作者：
Wang Xiao-Pei
Hu Zhang-Xue
Guo Dong-Yang
Tao Ye
机构：
[1] Chengdu
[2] Chengdu Military General Hospital
[3] Department of Nephrology
[4] Sichuan 610041
[5] Sichuan 610083
[6] Sichuan University
[7] West China Hospital
来源：
中华医学杂志英文版 | 2016年 / 129卷 / 07期
关键词：
Low-dose; Primary Membranous Nephropathy; Remission; Rituximab;
D O I：
暂无
中图分类号：
R692 [肾疾病];
学科分类号：
1002 ; 100210 ;
摘要：
Primary membranous nephropathy (PMN) is an antibody-mediated autoimmune glomerular disease. The incidence of PMN is 10/million populations/year and mostly adult patients present with nephrotic syndrom
引用
收藏
页码：871 / 873
页数：3
相关论文
共 50 条
  • [31] Reduced Dose Rituximab Is Effective in Recurrent Membranous Nephropathy
    Wagner, S. J.
    Saab, G.
    Java, A.
    Klein, C.
    Brennan, D. C.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2012, 12 : 380 - 380
  • [32] Rituximab-induced Remission Of Refractory Membranous Lupus Nephritis
    Abazi, Nora
    Kuzmanovska, Dafina
    Shahpazova, Emilija
    PEDIATRIC NEPHROLOGY, 2014, 29 (09) : 1736 - 1737
  • [33] Case report: One case of refractory membranous nephropathy with hypokalemia after rituximab infusion was switched to obinutuzumab without recurrence of hypokalemia
    Zhang, Yao
    Sun, Jing
    Gao, Jie
    Sun, Weiyan
    Xu, Liang
    Zhai, Chunjuan
    Su, WenYan
    Wang, Haiping
    FRONTIERS IN PHARMACOLOGY, 2024, 15
  • [34] Responsiveness to low-dose rituximab in refractory generalized myasthenia gravis
    Jing, Sisi
    Song, Yang
    Song, Jie
    Pang, Song
    Quan, Chao
    Zhou, Lei
    Huang, Yuyuan
    Lu, Jiahong
    Xi, Jianying
    Zhao, Chongbo
    JOURNAL OF NEUROIMMUNOLOGY, 2017, 311 : 14 - 21
  • [35] Low-dose rituximab is efficacious in refractory idiopathic inflammatory myopathies
    Janardana, Ramya
    Amin, S. N.
    Rajasekhar, Liza
    Pinto, Benzeeta
    Kodishala, Chanakya
    Selvam, Sumithra
    Shobha, Vineeta
    RHEUMATOLOGY, 2023, 62 (03) : 1243 - 1247
  • [36] EFFICACY OF RITUXIMAB IN A CASE OF PRIMARY MEMBRANOUS NEPHROPATHY
    Printza, Nikoleta
    Stabouli, Stella
    Dotis, John
    Georeli, Ireni
    Maliahova, Olga
    Sidira, Christina
    Papachristou, Fotios
    PEDIATRIC NEPHROLOGY, 2017, 32 (09) : 1777 - 1777
  • [37] EFFECT OF RITUXIMAB IN PATIENTS WITH RELAPSED OR REFRACTORY PRIMARY MEMBRANOUS NEPHROPATHY
    Akyildiz, Arif
    Uludag, Omer
    Mirioglu, Safak
    Ucar, Ali Riza
    Demir, Erol
    Caliskan, Yasar Kerem
    Ozluk, Yasemin
    Turkmen, Aydin
    Sever, Mehmet Sukru
    Yazici, Halil
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2020, 35 : 657 - 657
  • [38] Obinutuzumab versus rituximab for the treatment of refractory primary membranous nephropathy
    Xu, Mingyue
    Wang, Yifeng
    Wu, Meihe
    Chen, Ruiying
    Zhao, Wenqian
    Li, Mingxin
    Hao, Chuan-Ming
    Xie, Qionghong
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2024,
  • [39] Low Versus Standard Dose of Rituximab in Adult Patients with Relapsed or Refractory Primary Membranous Nephropathy: Does It Make Any Difference?
    Mirioglu, Safak
    Akyildiz, Arif
    Ucar, Ali Riza
    Uludag, Omer
    Ozluk, Yasemin
    Dirim, Ahmet Burak
    Demir, Erol
    Oto, Ozgur Akin
    Kilicaslan, Isin
    Caliskan, Yasar
    Yazici, Halil
    Turkmen, Aydin
    Sever, Mehmet Sukru
    TURKISH JOURNAL OF NEPHROLOGY, 2023, 32 (03): : 209 - +
  • [40] Retrospective analysis of leflunomide and low-dose methylprednisolone for the treatment of diabetic nephropathy combined with membranous nephropathy
    Shang, Shunlai
    Cui, Shaoyuan
    Wang, Wenjuan
    Wang, Chao
    Li, Ping
    Li, Wenge
    Li, Qinggang
    FRONTIERS IN ENDOCRINOLOGY, 2022, 13
12345